The prevention of prosthetic valve thromboembolism. Uses and limitations of anti-platelet drugs.
D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use*; D001705:Bioprosthesis; D004176:Dipyridamole / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D013442:Sulfinpyrazone / Q000627:therapeutic use*; D013923:Thromboembolism / Q000517:prevention & control*
D000925:Anticoagulants; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone